Pharmaceutical Supply Network Challenges Continue According to IMS Health Forecast
Written By: Brian Daleiden
Friday, October 23, 2009
Based on the recently released IMS Health industry forecast, it looks like the
macroeconomic trends driving increased complexity in pharmaceutical
manufacturing (both organic and contract manufacturing), supply chain
operations and sourcing will continue to grow. The question facing the
planning and operations leaders in these areas is how to get ahead of
this curve.
According to the new report, the seven "Pharmerging" markets comprised
of China, Brazil, India, South Korea, Mexico, Turkey and Russia will
contribute more than half of the expected global market growth in 2009.
While this share in 2009 is higher than the recent historical average,
these seven markets will be the source of more than 40 percent of total
global growth through 2013. This trend isn't surprising as these
countries are still climbing up the curve of broad access to primary
care, particularly in rural areas. Improved health insurance access is
stimulating improved health care regimens while the traditional focus on
acute care and infectious disease treatment is giving way to a new
focus on longer-term care of chronic illnesses such as cardiovascular
diseases and diabetes.
As this trend shows no signs of abating anytime soon, the question that
has been facing many of our customers is: Do we make tactical
adjustments in our manufacturing and supply chain plans or is now the
time to look at a strategic change in the way we do business? Markets
are becoming increasingly global yet at the same time the specific
desires of each country and region are becoming more local. In parallel,
the growing emphasis on operational improvement stimulates a desire for
global sourcing and global access to contract manufacturing, packaging
and distribution partners. This push into a more virtual environment is
straining traditional management processes and technologies to the
limit.
Is now the time to completely reexamine the foundation that all this
operates on?
Comments
Post has no comments.